Overview of the Therapeutic Potential of Aptamers Targeting Coagulation Factors
Aptamers are single-stranded DNA or RNA sequences that bind target molecules with high specificity and affinity. Aptamers exhibit several notable advantages over protein-based therapeutics. Aptamers are non-immunogenic, easier to synthesize and modify, and can bind targets with greater affinity. Due...
Main Authors: | Max Liu, Khalequz Zaman, Yolanda M. Fortenberry |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/8/3897 |
Similar Items
-
New High-Affinity Thrombin Aptamers for Advancing Coagulation Therapy: Balancing Thrombin Inhibition for Clot Prevention and Effective Bleeding Management with Antidote
by: Mohamad Ammar Ayass, et al.
Published: (2023-09-01) -
The Shorter the Better: Reducing Fixed Primer Regions of Oligonucleotide Libraries for Aptamer Selection
by: Weihua Pan, et al.
Published: (2009-03-01) -
Aptamers in Therapeutics
by: Abhishek Parashar
Published: (2016-06-01) -
Aptamer-based therapeutics and their potential in radiopharmaceutical design
by: Catia S. M. Ferreira, et al.
Published: (2007-09-01) -
Design and Prediction of Aptamers Assisted by In Silico Methods
by: Su Jin Lee, et al.
Published: (2023-01-01)